Fluorescent magnetic iron oxide nanoparticles for cardiac precursor cell selection from stromal vascular fraction and optimization for magnetic resonance imaging

Vinod Kumar Verma, Suguna Ratnakar Kamaraju, Ravindranath Kancherla, Lakshmi K. Kona, Syed Sultan Beev, Tanya Debnath, Shalini P. Usha, Rammohan Vadapalli, Ali Syed Arbab, Lakshmi Kiran Chelluri

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Fluorescent magnetic iron oxide nanoparticles have been used to label cells for imaging as well as for therapeutic purposes. The purpose of this study was to modify the approach to develop a nanoprobe for cell selection and imaging with a direct therapeutic translational focus. The approach involves physical coincubation and adsorption of superparamagnetic iron oxide nanoparticle-polyethylene glycol (SPION-PEG) complexes with a monoclonal antibody (mAb) or a set of antibodies. Flow cytometry, confocal laser scanning microscopy, transmission electron microscopy, iron staining, and magnetic resonance imaging were used to assess cell viability, function, and labeling efficiency. This process has been validated by selecting adipose tissue-derived cardiac progenitor cells from the stromal vascular fraction using signal regulatory protein alpha (SIRPA)/kinase domain receptor (KDR) mAbs. These markers were chosen because of their sustained expression during cardiomyocyte differentiation. Sorting of cells positive for SIRPA and KDR allowed the enrichment of cardiac progenitors with 90% troponin-I positivity in differentiation cultures. SPION labeled cardiac progenitor cells (1×105 cells) was mixed with gel and used for 3T magnetic resonance imaging at a concentration, as low as 12.5 µg of iron. The toxicity assays, at cellular and molecular levels, did not show any detrimental effects of SPION. Our study has the potential to achieve moderate to high specific cell selection for the dual purpose of imaging and therapy.

Original languageEnglish (US)
Pages (from-to)711-726
Number of pages16
JournalInternational Journal of Nanomedicine
Volume10
StatePublished - Jan 20 2015

Fingerprint

Magnetic resonance
Stromal Cells
Iron oxides
Nanoparticles
Blood Vessels
Magnetic Resonance Imaging
Imaging techniques
Protein Kinases
Stem Cells
Iron
Phosphotransferases
Troponin I
Nanoprobes
Proteins
Transmission Electron Microscopy
Cardiac Myocytes
Confocal Microscopy
Monoclonal antibodies
Flow cytometry
Adsorption

Keywords

  • Apoptosis
  • Cardiomyocyte
  • Cytotoxicity
  • Noninvasive molecular imaging
  • PEGylated nanoprobe

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Organic Chemistry
  • Drug Discovery

Cite this

Fluorescent magnetic iron oxide nanoparticles for cardiac precursor cell selection from stromal vascular fraction and optimization for magnetic resonance imaging. / Verma, Vinod Kumar; Kamaraju, Suguna Ratnakar; Kancherla, Ravindranath; Kona, Lakshmi K.; Beev, Syed Sultan; Debnath, Tanya; Usha, Shalini P.; Vadapalli, Rammohan; Arbab, Ali Syed; Chelluri, Lakshmi Kiran.

In: International Journal of Nanomedicine, Vol. 10, 20.01.2015, p. 711-726.

Research output: Contribution to journalArticle

Verma, VK, Kamaraju, SR, Kancherla, R, Kona, LK, Beev, SS, Debnath, T, Usha, SP, Vadapalli, R, Arbab, AS & Chelluri, LK 2015, 'Fluorescent magnetic iron oxide nanoparticles for cardiac precursor cell selection from stromal vascular fraction and optimization for magnetic resonance imaging', International Journal of Nanomedicine, vol. 10, pp. 711-726.
Verma, Vinod Kumar ; Kamaraju, Suguna Ratnakar ; Kancherla, Ravindranath ; Kona, Lakshmi K. ; Beev, Syed Sultan ; Debnath, Tanya ; Usha, Shalini P. ; Vadapalli, Rammohan ; Arbab, Ali Syed ; Chelluri, Lakshmi Kiran. / Fluorescent magnetic iron oxide nanoparticles for cardiac precursor cell selection from stromal vascular fraction and optimization for magnetic resonance imaging. In: International Journal of Nanomedicine. 2015 ; Vol. 10. pp. 711-726.
@article{92ba9c7ee7ed49ac88c04475dbd9fa50,
title = "Fluorescent magnetic iron oxide nanoparticles for cardiac precursor cell selection from stromal vascular fraction and optimization for magnetic resonance imaging",
abstract = "Fluorescent magnetic iron oxide nanoparticles have been used to label cells for imaging as well as for therapeutic purposes. The purpose of this study was to modify the approach to develop a nanoprobe for cell selection and imaging with a direct therapeutic translational focus. The approach involves physical coincubation and adsorption of superparamagnetic iron oxide nanoparticle-polyethylene glycol (SPION-PEG) complexes with a monoclonal antibody (mAb) or a set of antibodies. Flow cytometry, confocal laser scanning microscopy, transmission electron microscopy, iron staining, and magnetic resonance imaging were used to assess cell viability, function, and labeling efficiency. This process has been validated by selecting adipose tissue-derived cardiac progenitor cells from the stromal vascular fraction using signal regulatory protein alpha (SIRPA)/kinase domain receptor (KDR) mAbs. These markers were chosen because of their sustained expression during cardiomyocyte differentiation. Sorting of cells positive for SIRPA and KDR allowed the enrichment of cardiac progenitors with 90{\%} troponin-I positivity in differentiation cultures. SPION labeled cardiac progenitor cells (1×105 cells) was mixed with gel and used for 3T magnetic resonance imaging at a concentration, as low as 12.5 µg of iron. The toxicity assays, at cellular and molecular levels, did not show any detrimental effects of SPION. Our study has the potential to achieve moderate to high specific cell selection for the dual purpose of imaging and therapy.",
keywords = "Apoptosis, Cardiomyocyte, Cytotoxicity, Noninvasive molecular imaging, PEGylated nanoprobe",
author = "Verma, {Vinod Kumar} and Kamaraju, {Suguna Ratnakar} and Ravindranath Kancherla and Kona, {Lakshmi K.} and Beev, {Syed Sultan} and Tanya Debnath and Usha, {Shalini P.} and Rammohan Vadapalli and Arbab, {Ali Syed} and Chelluri, {Lakshmi Kiran}",
year = "2015",
month = "1",
day = "20",
language = "English (US)",
volume = "10",
pages = "711--726",
journal = "International Journal of Nanomedicine",
issn = "1176-9114",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Fluorescent magnetic iron oxide nanoparticles for cardiac precursor cell selection from stromal vascular fraction and optimization for magnetic resonance imaging

AU - Verma, Vinod Kumar

AU - Kamaraju, Suguna Ratnakar

AU - Kancherla, Ravindranath

AU - Kona, Lakshmi K.

AU - Beev, Syed Sultan

AU - Debnath, Tanya

AU - Usha, Shalini P.

AU - Vadapalli, Rammohan

AU - Arbab, Ali Syed

AU - Chelluri, Lakshmi Kiran

PY - 2015/1/20

Y1 - 2015/1/20

N2 - Fluorescent magnetic iron oxide nanoparticles have been used to label cells for imaging as well as for therapeutic purposes. The purpose of this study was to modify the approach to develop a nanoprobe for cell selection and imaging with a direct therapeutic translational focus. The approach involves physical coincubation and adsorption of superparamagnetic iron oxide nanoparticle-polyethylene glycol (SPION-PEG) complexes with a monoclonal antibody (mAb) or a set of antibodies. Flow cytometry, confocal laser scanning microscopy, transmission electron microscopy, iron staining, and magnetic resonance imaging were used to assess cell viability, function, and labeling efficiency. This process has been validated by selecting adipose tissue-derived cardiac progenitor cells from the stromal vascular fraction using signal regulatory protein alpha (SIRPA)/kinase domain receptor (KDR) mAbs. These markers were chosen because of their sustained expression during cardiomyocyte differentiation. Sorting of cells positive for SIRPA and KDR allowed the enrichment of cardiac progenitors with 90% troponin-I positivity in differentiation cultures. SPION labeled cardiac progenitor cells (1×105 cells) was mixed with gel and used for 3T magnetic resonance imaging at a concentration, as low as 12.5 µg of iron. The toxicity assays, at cellular and molecular levels, did not show any detrimental effects of SPION. Our study has the potential to achieve moderate to high specific cell selection for the dual purpose of imaging and therapy.

AB - Fluorescent magnetic iron oxide nanoparticles have been used to label cells for imaging as well as for therapeutic purposes. The purpose of this study was to modify the approach to develop a nanoprobe for cell selection and imaging with a direct therapeutic translational focus. The approach involves physical coincubation and adsorption of superparamagnetic iron oxide nanoparticle-polyethylene glycol (SPION-PEG) complexes with a monoclonal antibody (mAb) or a set of antibodies. Flow cytometry, confocal laser scanning microscopy, transmission electron microscopy, iron staining, and magnetic resonance imaging were used to assess cell viability, function, and labeling efficiency. This process has been validated by selecting adipose tissue-derived cardiac progenitor cells from the stromal vascular fraction using signal regulatory protein alpha (SIRPA)/kinase domain receptor (KDR) mAbs. These markers were chosen because of their sustained expression during cardiomyocyte differentiation. Sorting of cells positive for SIRPA and KDR allowed the enrichment of cardiac progenitors with 90% troponin-I positivity in differentiation cultures. SPION labeled cardiac progenitor cells (1×105 cells) was mixed with gel and used for 3T magnetic resonance imaging at a concentration, as low as 12.5 µg of iron. The toxicity assays, at cellular and molecular levels, did not show any detrimental effects of SPION. Our study has the potential to achieve moderate to high specific cell selection for the dual purpose of imaging and therapy.

KW - Apoptosis

KW - Cardiomyocyte

KW - Cytotoxicity

KW - Noninvasive molecular imaging

KW - PEGylated nanoprobe

UR - http://www.scopus.com/inward/record.url?scp=84921878398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921878398&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 711

EP - 726

JO - International Journal of Nanomedicine

JF - International Journal of Nanomedicine

SN - 1176-9114

ER -